Drug Profile
Captopril liquid - Proveca
Alternative Names: Captopril liquidLatest Information Update: 28 Jan 2023
Price :
$50
*
At a glance
- Originator Proveca
- Class Antihypertensives; Heart failure therapies; Small molecules
- Mechanism of Action ACE inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Heart failure
Most Recent Events
- 28 Jan 2023 No recent reports of development identified for phase-I development in Heart-failure in Spain (PO, Liquid)
- 11 Dec 2019 Phase-I clinical trials in Heart failure in Spain (PO) (EudraCT2019-000258-76)
- 11 Dec 2019 Preclinical trials in Heart failure in Spain (PO) (EudraCT2019-000258-76)